SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-029891
Filing Date
2023-08-23
Accepted
2023-08-23 08:51:04
Documents
15
Period of Report
2023-08-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41071
2 ex99-1.htm EX-99.1 91858
3 ex99-2.htm EX-99.2 30763
4 ex99-1.jpg GRAPHIC 11173
  Complete submission text file 0001493152-23-029891.txt   382659

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aim-20230823.xsd EX-101.SCH 3015
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aim-20230823_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aim-20230823_pre.xml EX-101.PRE 22360
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3212
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 231195362
SIC: 2836 Biological Products, (No Diagnostic Substances)